Novel left ventricular mechanical index in pulmonary arterial hypertension.
Kenzo IchimuraEverton J SantanaTatiana KuznetsovaNicholas CauwenberghsFrantišek SabovčikLindsey ChunNadia L C FranciscoVitaly O KheyfetsMichael SalernoRoham T ZamanianEdda SpiekerkoetterFrancois HaddadPublished in: Pulmonary circulation (2023)
Ventricular interdependence plays an important role in pulmonary arterial hypertension (PAH). It can decrease left ventricular (LV) longitudinal strain (LVLS) and lead to a leftward displacement ("transverse shortening") of the interventricular septum (sTS). For this study, we hypothesized the ratio of LVLS/sTS would be a sensitive marker of systolic ventricular interactions in PAH. In a cross-sectional cohort of patients with PAH ( n = 57) and matched controls ( n = 57), we quantified LVLS and septal TS in the amplitude and time domain. We then characterized LV phenotypes using upset plots, ventricular interactions using network analysis, and longitudinal analysis in a representative cohort of 45 patients. We also measured LV metrics in mice subjected to pulmonary arterial banding (PAB) using a 7 T magnetic resonance imaging at baseline, Week 1, and Week 7 post-PAB ( N = 9). Patients with PAH had significantly reduced absolute LVLS (15.4 ± 3.4 vs. 20.1 ± 2.3%, p < 0.0001), higher sTS (53.0 ± 12.2 vs. 28.0 ± 6.2%, p < 0.0001) and lower LVLS/sTS (0.30 ± 0.09 vs. 0.75 ± 0.16, p < 0.0001) compared to controls. Reduced LVLS/sTS was observed in 89.5% of patients, while diastolic dysfunction, impaired LVLS (<16%), and LV atrophy were observed in 73.7%, 52.6%, and 15.8%, respectively. In the longitudinal cohort, changes in LVLS/sTS were closely associated with changes in N-terminal pro B-type natriuretic peptide ( r = 0.73, p < 0.0001) as well as survival. Mice subjected to PAB showed significant RV systolic dysfunction and decreased LVLS/sTS compared to sham animals. We conclude that in PAH, LVLV/sTS is a simple ratio that can reflect ventricular systolic interactions.
Keyphrases
- left ventricular
- pulmonary arterial hypertension
- heart failure
- cardiac resynchronization therapy
- hypertrophic cardiomyopathy
- end stage renal disease
- magnetic resonance imaging
- pulmonary hypertension
- aortic stenosis
- ejection fraction
- blood pressure
- left atrial
- acute myocardial infarction
- chronic kidney disease
- mitral valve
- pulmonary artery
- cross sectional
- newly diagnosed
- mycobacterium tuberculosis
- coronary artery
- randomized controlled trial
- insulin resistance
- prognostic factors
- type diabetes
- patient reported outcomes
- metabolic syndrome
- high fat diet induced
- placebo controlled
- study protocol